The Chinese biotech market is at a nascent stage, when compared to its counterpart in the US, Europe, and Japan. The country, however, has the potential to dominate the world biotech market. Its cheap labor costs, strong biodiversity, immense government support, and a huge pool of human resources are enabling the country to flourish in every segment of the biotech. The biotechnology capabilities of China can be envisaged from the fact that, the country not only represents a strong destination for exports, but also promises a huge domestic market. Consequently, the biotech market in China is forecasted to grow at a CAGR of around 23% during 2010 - 2012, says our new research report “Asia Pacific Biotechnology Market (2008-2012)”.